Skip to content

Factor Xiii A Subunit Deficiency Of C2750514

Published: July 22, 2026Updated: August 20, 2026

Factor XIII A subunit deficiency is a rare inherited bleeding disorder where blood clots fail to stabilize properly. It can cause prolonged bleeding after injury, surgery, or spontaneous bleeding episodes. Treatment with factor XIII replacement therapy helps prevent bleeding complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Intracranial hemorrhage

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Poor wound healing

(hematologic)

Umbilical stump bleeding

(hematologic)

Post-traumatic bleeding

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Cryoprecipitate Transfusion

Cryoprecipitate contains Factor XIII and fibrinogen, used for acute bleeding or as prophylaxis before surgical procedures.

medication
2

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Factor XIII Concentrate

Purified Factor XIII concentrate provides targeted replacement with lower infection risk compared to plasma products.

medication

Additional treatment options

Factor XIII Level Testing

Regular monitoring of Factor XIII levels helps guide prophylaxis schedules and prevent breakthrough bleeding episodes.

monitoring

Avoidance of Trauma-prone Activities

Patients should avoid activities with high injury risk since Factor XIII deficiency causes delayed bleeding complications.

lifestyle

Patient Education and Emergency Planning

Comprehensive education on bleeding recognition, emergency care protocols, and medical alert identification improves outcomes.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Factor Xiii A Subunit Deficiency Of C2750514?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Factor Xiii A Subunit Deficiency Of C2750514. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy